© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, AGF U.S. Market Neutral Anti-Beta Fund (BTAL) shows an Average True Range (ATR) of 0.27 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 660.89K, indicating liquidity. These fundamental metrics provide insight into BTAL's underlying financial health and market activity.
| ATR | 0.27 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 660.89K |
| Avg Vol (10 Days) | 819.36K |
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) technical indicators as of September 11, 2026: the SMA 20 is -1.53%, SMA 50 at -2.23%, and SMA 200 at -13.26%. The RSI 14 value is 44.86, suggesting its current momentum. These technical analysis signals help assess BTAL's price trends and potential future movements.
| SMA 20 | -1.53% |
| SMA 50 | -2.23% |
| SMA 200 | -13.26% |
| RSI 14 | 44.86 |
AGF U.S. Market Neutral Anti-Beta Fund (BTAL) stock performance overview as of September 11, 2026: The 52-week high is N/A (currently -37.56% below), and the 52-week low is N/A (currently 1.4% above). Over the past year, BTAL's performance is N/A, compared to the S&P 500's 1.11% change.
| 52-Week High | N/A |
| 52-Week High Chg | -37.56% |
| 52-Week Low | N/A |
| 52-Week Low Chg | +1.40% |
| S&P 500 52-Week Chg | 1.11% |
According to current financial data, BTAL stock's P/E (TTM) ratio is N/A, which compares to the S&P 500's P/E of 32.59. The sector median P/E is 7.31. Key valuation ratios for BTAL, including P/S (N/A), P/B (N/A), and P/FCF (N/A), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | BTAL | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | N/A | 7.31 | 932.18 | 32.59 |
| P/S (TTM) | N/A | 6.63 | -515523.24 | 5.98 |
| P/B (TTM) | N/A | 0.86 | -163928.16 | 5.47 |
| P/FCF (TTM) | N/A | 13.98 | -6416.99 | 28.11 |